Clinical outcome assessments are intellectual property. The widely used questionnaires, scales, and diaries in oncology, neurology, mental health, and rare disease are protected by copyright, and almost all of them require a formal license for use in a clinical trial.
Licensing terms are not standardized. Some developers offer free academic use but charge for commercial trials. Some restrict electronic implementation. Many require separate permissions for each language version, and a few license the instrument but charge again for any translation or migration to a new platform.
The most common failure mode is timing: trial teams assume permissions can be sorted in parallel with country approvals, then discover that the developer requires 8–12 weeks of review and may not authorize the languages or modes the protocol depends on.
We build a permissions map at the same time as the language plan: instrument, languages, modes (paper/eCOA), derivative rights, sublicense rights, and renewal terms. Surprises caught at planning are cheap. Surprises caught at database lock are not.